Using Clinical PK/PD Studies to Support No Clinically Meaningful Differences Between a Proposed Biosimilar and the Reference Product
Crossref DOI link: https://doi.org/10.1208/s12248-018-0246-1
Published Online: 2018-08-09
Published Print: 2018-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Peijuan http://orcid.org/0000-0003-3636-7640
Ji, Ping
Wang, Yaning
Text and Data Mining valid from 2018-08-09
Article History
Received: 10 January 2018
Accepted: 9 July 2018
First Online: 9 August 2018